Introducing regenerative creams, regenerative ampoules, mask packs, and acne patches based on our proprietary h-dECM and PDRN technology.
Launching innovative medical device products specifically targeted for the treatment of intractable acne, melasma, and erythema.
Establishment of specialized procedure centers based on the Re2DN product line and our advanced cellular regeneration protocols.
Supercritical fluid-based ECM molecular size reduction
Hydrolyzed dECM showed a reduction in molecular weight from 13,520 Da to 3,089 Da while preserving key ECM components, and fluorescence analysis confirmed its delivery into the dermal layer.
Fibroblast activation and ECM remodeling induced by hydrolyzed dECM
Hydrolyzed dECM activated fibroblasts and increased CTGF expression by approximately 2.8-fold, demonstrating a biological response associated with ECM remodeling.
VEGF Upregulation observed with hydrolyzed dECM
Increased VEGF expression indicates a biological response associated with angiogenesis and the regenerative microenvironment.
Everyday cell regeneration. Infused with our proprietary h-dECM and PDRN complexes to reverse environmental damage and cellular aging from the comfort of your home.
An intensive care lip balm formulated with h-dECM and Volufiline, designed to hydrate dry, rough lips while supporting the lip barrier and enhancing volume.